Clinical trial
Comparison of Two Treatment Regimens to Reduce PA Infection in Children With…
NCT00097773 · Seattle Children's Hospital, Other · Completed
Key facts
| NCT number | NCT00097773 |
|---|---|
| Title | Comparison of Two Treatment Regimens to Reduce PA Infection in Children With Cystic Fibrosis |
| Official title | Effectiveness and Safety of Intermittent Antimicrobial Therapy for the Treatment of New Onset Pseudomonas Aeruginosa Airway Infection in Young Patients With Cystic Fibrosis |
| Acronym | EPIC |
| Lead sponsor | Seattle Children's Hospital, Other |
| Collaborators | National Heart, Lung, and Blood Institute (NHLBI) NIH Cystic Fibrosis Foundation CF Therapeutics Development Network Coordinating Center |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cystic Fibrosis, Pulmonary Disease, Chronic Obstructive |
| Intervention type | Drug |
| Interventions | Tobramycin solution for inhalation (TOBI), Oral placebo, Oral ciprofloxacin |
| Enrollment | 304 |
| Start date | Sep 1, 2004 |
| Primary completion | Jun 1, 2009 |
| Completion | Aug 1, 2009 |
| First posted | Dec 1, 2004 |
| Last update posted | Feb 28, 2014 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: